High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$17.3M
$17,291,026
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
JNJ
S
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -62.7%
2026-02-17
$5,278,203Whale
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -62.7%
|
2026-02-17 | $5,278,203Whale | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -69.8%
2026-02-17
$7,272,261Whale
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -69.8%
|
2026-02-17 | $7,272,261Whale | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -17.6%
2026-02-17
$554,769
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -17.6%
|
2026-02-17 | $554,769 | S | Form 4 |
|
JNJ
M
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Other
2026-02-17
$3,430,180Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Other
|
2026-02-17 | $3,430,180Large | M | Form 4 |
|
JNJ
M
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Other
2026-02-17
$4,673,101Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Other
|
2026-02-17 | $4,673,101Large | M | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -67.1%
2025-10-17
$4,185,793Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -67.1%
|
2025-10-17 | $4,185,793Large | S | Form 4 |
|
JNJ
M
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Other
2025-10-17
$3,430,180Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Other
|
2025-10-17 | $3,430,180Large | M | Form 4 |